中国防痨杂志2026，Vol.48Issue(5)：561-566,6.DOI:10.19982/j.issn.1000-6621.20250401
我国风湿免疫病患者结核分枝杆菌潜伏感染筛查现况与优化路径探讨
Current status and optimization paths of latent tuberculosis infection screening in patients with rheumatic immune diseases in China
摘要
Abstract
Tuberculosis is an infectious disease that poses a serious threat to human health.Patients with rheumatic diseases have much higher risk of tuberculosis infection than the general population due to impaired autoimmune systems and the influence of drugs.Screening for latent tuberculosis infection and providing preventive treatment are of great significance for controlling the condition and reducing the spread of tuberculosis.However,clinical screening still faces multiple predicaments such as complex disease characteristics,insufficient adaptability of screening technologies and uneven resource allocation,non-standard clinical decision-making,and the lack of community management.This article elaborates on the prevalence of latent tuberculosis infection in rheumatic diseases patients,screening techniques and resource allocation,clinical decision-making,preventive treatment and management,etc.,to explore effective ways to increase the screening rate.It conducts in-depth analysis from multiple aspects,explores the paths to improve the screening rate,provides references for relevant policy making,helps improve patient prognosis,and reduces the burden on social medical care.关键词
风湿性疾病/结核/分枝杆菌感染/综合预防/感染控制Key words
Rheumatic diseases/Tuberculosis/Mycobacterium infections/Universal precautions/Infection control分类
医药卫生引用本文复制引用
高丽,张国钦..我国风湿免疫病患者结核分枝杆菌潜伏感染筛查现况与优化路径探讨[J].中国防痨杂志,2026,48(5):561-566,6.基金项目
Tianjin High-level Talent Selection and Training Project in Health Profession(TJSQNYXXR-D2-117) （TJSQNYXXR-D2-117）
Tianjin Health Research Project(TJWJ2025RC019) （TJWJ2025RC019）
Science and Technology Fund of Tianjin Center for Tuberculosis Control(JHKJ202502) 天津市卫生健康行业高层次人才选拔培养工程(TJSQNYXXR-D2-117) （JHKJ202502）
天津市卫生健康科技项目(TJWJ2025RC019) （TJWJ2025RC019）
天津市结核病控制中心科技基金(JHKJ202502) （JHKJ202502）
